期刊文献+

第10号染色体缺失的磷酸酶和张力蛋白同源基因在口腔鳞状细胞癌中的作用

Effect of phosphatase and tensin homolog gene deleted on chromosome 10 in oral squamous cell carcinoma
下载PDF
导出
摘要 第10号染色体缺失的磷酸酶和张力蛋白同源基因(PTEN)可通过信号转导通路调控细胞周期,影响细胞的生长发育和程序性死亡,参与调节细胞的迁移和黏附,维护免疫系统的稳定。在口腔鳞状细胞癌(OSCC)的发生发展过程中,可能并不存在PTEN基因的突变和缺失,却可能与PTEN m RNA表达水平降低有一定的关系。PTEN蛋白在健康黏膜和口腔黏膜下纤维性变(OSF)到OSCC的不同组织学类型标本中表达逐渐下降,是OSF的发病机制和恶性转化机制中的重要分子事件。PTEN蛋白与OSCC的组织学和生物学行为有关,可作为其未来的预后指标。在多种肿瘤中,各种调控所导致PTEN蛋白的低表达,影响PTEN蛋白参与的多级信号转导,导致其在协调细胞周期进展,控制程序性细胞死亡及细胞黏附,抑制癌细胞转移和增殖等方面难以发挥预期的作用。 Phosphatase and tensin homolog gene deleted on chromosome 10(PTEN) plays an essential role not only in cell cycle regulation, limiting cell growth, and proliferation, but also in cell migration regulation, adhesion, and maintenance of the stability of the immune system through the signal transduction pathway. The PTEN gene may not undergo mutation and deletion during the development of oral squamous cell carcinoma(OSCC) but may be specifically related to the reduction of the PTEN mRNA expression level. The PTEN protein exhibits decreased expression in different histological types of specimens, ranging from healthy oral mucosa and oral submucous fibrosis(OSF) to OSCC. This event is important in the pathogenesis and malignant transformation mechanism of OSF. The expression of the PTEN protein is related to the histological and biological behavior of OSCC and can be used as a prognostic indicator of OSCC. The low expression of the PTEN protein caused by different factors may cause difficulty in performing its role on coordination of cell cycle, control of programmed cell death and cell adhesion, inhibition of metastasis and proliferation of cancer cells.
出处 《国际口腔医学杂志》 CAS 北大核心 2015年第3期334-338,共5页 International Journal of Stomatology
基金 国家自然科学基金(30872891)
关键词 口腔鳞状细胞癌 癌前病变 第10号染色体缺失的磷酸酶和张力蛋白同源基因 表达 调控 信号转导机制 oral squamous cell carcinoma precancerous lesion phosphatase and tensin homology gene deleted onchromosome ten expression regulation signal transduction mechanism
  • 相关文献

参考文献33

  • 1Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer[J]. Science, 1997, 275 (5308):1943-1947.
  • 2Steck PA, Pershouse MA, Jasser SA, et al. Identi- fication of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers[J]. Nat Genet, 1997, 15 (4):356-362.
  • 3Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phos- phatase regulated by transforming growth factor beta[J]. Cancer Res, 1997, 57(11):2124-2129.
  • 4Bleau AM, Hambardzumyan D, Ozawa T, et al. PTEN/PI3K/Akt pathway regulates the side popula- tion phenotype and ABCG2 activity in glioma tumor stem-like cells[J]. Cell Stem Cell, 2009, 4(3):226- 235.
  • 5Zhang M. PTEN in action: coordinating with p53 to regulate maspin gene expression[J]. Cell Cycle, 2009, 8(8):1112-1113.
  • 6Srividya MR, Thota B, Shailaja BC, et al. Homozy- gous 10q23/PTEN deletion and its impact on outcome in glioblastoma: a prospective translational study on a uniformly treated cohort of adult patients[J]. Neu- ropathology, 2011, 31(4):376-383.
  • 7de Muga S, Hemttndez S, Agell L, et al. Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas[J]. Mod Pathol, 2010, 23(5):703-712.
  • 8Chen Q, Samaranayake LP, Zhou H, et al. Homozy- gous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma[J]. Oral Oncol, 2000, 36(1):95-99.
  • 9Mavros A, Hahn M, Wieland I, et al. Infrequent genetic alterations of the tumor suppressor gene PTEN/MMAC1 in squamous cell carcinoma of the oral cavity[J]. J Oral Pathol Med, 2002, 31(5):270- 276.
  • 10李倩,赵继志,陈永宁,张韬,周炼,金晔.口腔鳞状细胞癌中蛋白酪氨酸磷酸酶基因的突变与表达[J].中华口腔医学杂志,2009,44(11):660-663. 被引量:3

二级参考文献52

  • 1沈权,陈泽,刘旭萍,邢海燕,王敏,王建祥.抑癌基因PTEN mRNA在白血病细胞中的表达及意义[J].中华血液学杂志,2005,26(8):493-496. 被引量:20
  • 2郭欣,陈春悠,黎洁.端粒酶逆转录酶在涎腺恶性肿瘤中的表达[J].中国综合临床,2006,22(11):1033-1035. 被引量:1
  • 3Davies L, Welch HG. Epidemiology of head and neck cancer in the United States. Otolaryngol Head Neck Surg, 2006,135 (3) : 451-457.
  • 4Rogers SN, Brown JS, Woolgar JA, et al. Survival following primary surgery for oral cancer. Oral Oncol, 2009, 45 ( 3 ) :201-211.
  • 5Chen PH, Shieh TY, Ho PS, et al. Prognostic factors associated with the survival of oral and pharyngeal carcinoma in Taiwan. BMC Cancer,2007, 7:101.
  • 6Seully C, Bagan JV. Recent advances in oral oncology 2007: imaging, treatment and treatment outcomes. Oral 0ncol, 2008, 44(3) :211-215.
  • 7Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosin phosphatase gene mutated in human brain, breast, and prostate cancer. Science, 1997, 275 (5508) : 1945-1947.
  • 8Shen YH, Zhang L, Utama B, et al. Human cytomegalovirus inhibits Akt-mediated eNOS activation through upregulating PTEN (phosphatase and tensin homolog deleted on chromosome 10). Cardiovasc Res, 2006, 69(2): 502-511.
  • 9Lacey JV Jr, Mutter GL, Ronnett BM, et al. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res, 2008,68(14) :6014-6020.
  • 10Bonneau D, Longy M. Mutations of the human PTEN gene. Hum Murat, 2000,16 (2) : 109-122.

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部